Luis Ruiz Guerrero

Cardiologist. Inherited Cardiovascular Diseases. Cardiopatías y Aortopatías Familiares. @HUnivValdecilla H.U. Marqués de Valdecilla. Santander. 🇪🇸

[Ahmad Masri @MasriAhmadMD]

ACACIA-HCM trial topline results - aficamten in nHCM. Incredibly proud and thankful to our patients and team for their commitment and hard work. This represents the first effective treatment for patients with nHCM. looking forward to seeing the full results.
#CardioTwitter

[JACC Journals @JACCJournals]

Danicamtiv enhanced cardiac myosin function in vitro and was generally well tolerated in #DCM. Echo findings suggest improved contractility, with strongest responses in #MYH7 and TTN cohorts https://t.co/OS5zxv1hLT #JACC #cvDCM

[Ahmad Masri @MasriAhmadMD]

Early-onset AF, especially without risk factors --> myocardial disease --> genetic evaluation

https://t.co/XgiQAfNl3y

#CardioTwitter

[Ahmad Masri @MasriAhmadMD]

RBM20 cardiomyopathy carries a more significant burden at a younger age, and an accelerated course compared to TTN cardiomyopathy

https://t.co/C2807uJKO1

#CardioTwitter

[Ahmad Masri @MasriAhmadMD]

A deep dive into the mechanisms of ALPK3 associated HCM

#CardioTwitter

https://t.co/ugyXOK0gDv

[Europace Editor-in-Chief @EuropaceEiC]

📣New Consensus is out in #Europace
#EHRA2025

💊The diagnostic role of pharmacological provocation testing in cardiac electrophysiology💥

🔗 https://t.co/dBURg9uRkd

@GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @DavideMei93 @marcovitoloMD @LuigiDiBiaseMD

[American College of Cardiology @ACCinTouch]

Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study presented during a Late-Breaking Clinical Trial session at #ACC25.

Check out the key findings ��️ https://t.co/hVqEY34Uie

[HeartRhythm @hrs_journal]

Late Gadolinium Enhancement in Early Repolarization Syndrome

https://t.co/5CvL534T6P

[Roberto Barriales-Villa @rbarvil]

📅 The A Coruña Hypertrophic Cardiomyopathy Congress is Back!
🗓 September 18-19, 2025
🔬 Experts from 🇦🇷 🇦🇺 🇩🇪 🇪🇸 🇫🇷 🇬🇧 🇮🇹 🇳🇱 🇵🇹 🇺🇸 @seccCFyGenetCV @secardiologia
🔗 https://t.co/NQHuCS0lBW

[Circulation @CircAHA]

Low penetrance sarcomere variants (LowSVs) contribute to mild HCM alone but increase severity with high-risk variants. @neallakdawala @drjamesware @tikuowens @jodieingles27 @S2beri @sday_hcm @SeanLZheng @AdamHelmsMD https://t.co/26ffpOKTOE

[JACC Journals @JACCJournals]

🧬 24% of patients with heritable arrhythmias & cardiomyopathies carry a disease-causing variant—but only 8% see changes in clinical management. How do we close the gap? Read the study: https://t.co/AhDq8BbqFR

#JACC #Genetics #CardioScience #PrecisionMedicine #cvGenetics

[NEJM Evidence @NEJMEvidence]

Cardiopulmonary exercise testing (CPET) has a unique role in the assessment of cardiopulmonary disease. @BrazileTiffany and colleagues review key CPET variables, protocols and clinical indications. https://t.co/0Wgjt1XLCf

[NEJM @NEJM]

Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors. Learn more: https://t.co/b6tbHu2J97

[Hunain Shiwani @HunainShiwani]

🔬New in @JACCJournals: HCM diagnosis criteria show unexpected demographic bias. Study of 50,000+ hearts reveals current thresholds create 8:1 male-female ratio

Proposing demographic-adjusted thresholds to improve diagnosis🫀

https://t.co/GoRmh9eGmC

@UCL_ICS @NHSBartsHealth

[Jon Zubiaur Zamacola @JonZubiaur]

I am very happy to end 2024 with the publication of our study "Validation of a hand-held ultrasound device in the evaluation of aortic stenosis".

Thanks to all the collaborators @raquelpbarquin #AdrianMargarida @HUnivValdecilla @IDIVALdecilla

https://t.co/cVHRt2JLFJ

[John Mandrola, MD @drjohnm]

This is nice work on an important question in EP. I have an idea about a subgroup. Mandrola theory of de novo AFlutter. If it occurs in pt w prior heart surgery, CTI likely enough. If no prior surgery, CTI + PVI better. #epeeps

LOE 👆= opinion. #EPeeps

[John Mandrola, MD @drjohnm]

As promised, here is a slew of content ...re the PLATO trial of ticagrelor vs clopidogrel in patients with ACS

This all occurred in 2009, early in my critical appraisal learning.

Revisiting PLATO controversy is super important--both clinically and epistemologically

[American College of Cardiology @ACCinTouch]

🗝️ Collecting a detailed family history and pertinent clinical data for patients with cardiomyopathies is needed to guide potential use of genetic testing.

Read more key points on genetic testing for cardiomyopathies ➡️ https://t.co/3aNgt4FXw2 #HeartFailure

[JM Larrañaga @xenux88]

2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee | Journal of the American College of Cardiology https://t.co/7dLvbyTAhV

[JM Larrañaga @xenux88]

How to include mDNA in HCM genetic panels? https://t.co/Yilnnru8OM